Effects of medications on plasma amyloid beta (Abeta) 42: longitudinal data from the VITA cohort.
about
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseCSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer's DiseasePlasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.Platelet-derived secreted amyloid-precursor protein-β as a marker for diagnosing Alzheimer's disease.Brain metabolic dysfunction at the core of Alzheimer's disease.High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer's disease patientsSerum Abeta levels as predictors of conversion to mild cognitive impairment/Alzheimer disease in an ADAPT subcohort.Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study.Pharmacological modulation of dietary lipid-induced cerebral capillary dysfunction: Considerations for reducing risk for Alzheimer's disease.Glial markers and emotional memory in rats following acute cerebral radiofrequency exposures.Matrix metalloproteinases-2 and -3 are reduced in cerebrospinal fluid with low beta-amyloid1-42 levels.The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer's disease.
P2860
Q27021700-556A7610-1A7B-4B03-B835-96B0CF051B84Q28259585-6D2CBD6C-42FB-4F9D-8399-2293D93ACD34Q33896118-11F17386-16F6-404E-BFC6-016A06540070Q34292024-75FC5A95-D835-48F4-A5EB-2D0FBE641671Q35029908-382D3DC5-0FBA-4A8E-971C-B0635908EFA8Q35997881-12636CE2-F21B-49DC-A8E4-7C42675C4BF7Q37009902-DFB2708D-C3B9-493C-9AD1-EE62EFDBE555Q37314262-6B79878A-7700-4838-97EC-2729CEEA996FQ38597149-E19AC844-A324-4FAC-87C3-EE01E7425588Q38672178-BAB9EC33-001E-4BD2-BD36-01EB472249ADQ39328965-99DD7FC8-BB6A-4233-806D-73741B6D068AQ41898767-221F2047-91F7-4037-B9B7-ED3809404569Q47155881-FC3D11CE-5F6C-4091-A48C-A0150CDD89ED
P2860
Effects of medications on plasma amyloid beta (Abeta) 42: longitudinal data from the VITA cohort.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Effects of medications on plas ...... nal data from the VITA cohort.
@ast
Effects of medications on plas ...... nal data from the VITA cohort.
@en
type
label
Effects of medications on plas ...... nal data from the VITA cohort.
@ast
Effects of medications on plas ...... nal data from the VITA cohort.
@en
prefLabel
Effects of medications on plas ...... nal data from the VITA cohort.
@ast
Effects of medications on plas ...... nal data from the VITA cohort.
@en
P2093
P1476
Effects of medications on plas ...... nal data from the VITA cohort.
@en
P2093
Georg Kemmler
Hartmann Hinterhuber
Ildiko Wichart
Imrich Blasko
Karl Heinz Tragl
Kurt Jellinger
Peter Fischer
Silvia Weissgram
Susanne Jungwirth
Wolfgang Krampla
P304
P356
10.1016/J.JPSYCHIRES.2007.10.010
P577
2007-12-21T00:00:00Z